Insulin lispro: The ideal pump insulin for patients with severe hypoglycemic unawareness? [13]

Diabetes Care

Volumn 22, Issue 9, 1999, Pages 1598-1599

  Ooi, Cheong ^a   Mullen, Peter ^a   Williams, Gareth ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN LISPRO;

GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; LETTER; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT INDICATION;

AWARENESS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED;

EID: 0032859023     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.9.1598     Document Type: Letter

References (4)

1. Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH, the Benelux-UK Insulin Lispro Study Group: Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. Diabetes Care 20:1827-1832, 1997
2. Schmau S, Konig A, Landgraf R: Human insulin analogue [LYS (B28), PRO (B29)]: the ideal pump insulin? Diabetic Med 15:247-249, 1998
3. 1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 21:977-982, 1998
4. Schlichtkull J, Munck O, Jersild M: The M value: an index of blood sugar control in diabetics. Acta Med Scand 177:95-102, 1965